Skip to main content

Unable to load price data. Sorry.



CAPS Rating: No stars

A biopharmaceutical company which deals in improving the lives of patients by developing novel protein, fully-human monoclonal antibody, antibody-drug conjugate, and small molecule therapeutics for the treatment of cancer and cancer supportive care.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:CRGN.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NetscribeHealthC (72.69)
Submitted March 08, 2007

CuraGen Corporation (CRGN) is a biopharmaceutical company developing diverse approaches, including novel protein, antibody, and small molecule therapeutics that aim to offer hope for patients with cancer, inflammatory diseases, and diabetes. To… More

majakblue (< 20)
Submitted June 28, 2007

Another pharma wannabe dead. I shouldn't even bother except that the majority of all-stars gave a thumbs up. You should invest in early stage drug companies if you are rich and need a tax shelter. Most of these start-ups are either scientists in big… More



  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CRGN.DL.

No one has written a Pitch for CRGN.DL stock yet. Tell us why you think CRGN.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in CRGN.DL.

No players have picked CRGN.DL yet. Tell us why you think CRGN.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CRGN.DL.